Pill Shows Benefit in Certain Hard-to-Treat Breast Cancers


Researchers are reporting promising results from a medicine that appears to help keep at bay certain early stage hard to treat forms of breast cancer it's a pill called Lynparza marketed by AstraZeneca and Merck and already in use to treat some widely spread cancers but a study released by the American society of clinical oncology says Lynparza appears to help breast cancer patients with harmful mutations live longer without disease after their cancers had been treated with surgery and chemotherapy it was studied in patients with mutations known as BRCA one and two which can predispose people to breast cancer out of nearly two thousand women and men with early stage breast cancer eighty six percent were still alive after three years after taking the pill compared to seventy seven percent in the placebo group I'm Jackie Quinn

Coming up next